Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about RHHBY

Recent news which mentions RHHBY

< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
Omeros' New Leukemia Drug Team Ignites Hope For Cancer Fight
Tickers ABBV BMY NEWS OMER
Tags Market News Analyst Color OMER
From Benzinga
Tempest Weighs M&A, Analyst Sees A "Broken Story" Despite Phase 2 Liver Cancer Study Success
Tickers AZN BMY NEWS RHHBY
Tags Biotech AstraZeneca Downgrades
From Benzinga
Pharma Industry Faces Jitters As Trump Hints At Historic Tariffs, BofA Outlines Probable Timeline
Tickers ARGX AZN GILD GSK
Tags Expert Ideas GSK LLY
From Benzinga
Why Roche Holding, Eli Lilly, and AstraZeneca Stocks Dropped Today
Tickers AZN LLY RHHBY
Tags Recent Press Releases RHHBY LLY
From Motley Fool
Roche To Start Phase 3 Study For Alzheimer's Prospect This Year After New Data From Phase 2
Tickers NEWS RHHBY
Tags Biotech Benzinga Stories That Matter
From Benzinga
Trump Tariffs Spare Drugmakers But Threaten Diabetes Device Industry
Tickers BSX DXCM EW NEWS
Tags PODD tariffs EW
From Benzinga
Sarepta/Roche Suspend Elevidys Gene Therapy Trials In Europe After Patient Death
Tickers NEWS RHHBY SRPT
Tags Benzinga SRPT Biotech
From Benzinga
Why Is Pharma Giant Roche Stock Trading Lower On Wednesday?
Tickers NEWS RHHBY
Tags Benzinga Biotech Stories That Matter
From Benzinga
Pharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed
Tickers AMGN AZN BIIB BMY
Tags Briefs UCBJY Eurozone
From Benzinga
Novartis New Data From Single-Dose Gene Therapy Shows Meaningful Efficacy, Safety In Patients With Spinal Muscular Atrophy
Tickers BIIB NEWS NVS RHHBY
Tags Market News NVS News
From Benzinga
The Best Vanguard ETF to Invest $1,000 in Right Now
Tickers NSRGY NVS RHHBY SAP
Tags Recent Press Releases SAP SPGI
From Motley Fool
Why Viking Therapeutics and Roche Holdings Popped Today, but Novo Nordisk Stock Dropped
Tickers LLY NVO RHHBY VKTX
Tags LLY NVO VKTX
From Motley Fool
Roche Further Boosts Obesity Pipeline With Zealand Pharma Deal Worth $5.3 Billion For Weight Loss Drugs
Tickers NEWS RHHBY
Tags Large Cap Stories That Matter Benzinga
From Benzinga
Roche Touts Food Allergy Drug As Superior Than Oral Immunotherapy
Tickers NEWS NVS RHHBY
Tags Large Cap Biotech Benzinga
From Benzinga
NovoCure Q4 EPS Misses, Revenue Matches
Tickers MRK NVCR RHHBY ZLAB
Tags MRK Market News RHHBY
From Motley Fool
Teva's Duvakitug Set To Shake Up IBD Treatment, Analyst Highlights Competitive Data
Tickers NEWS RHHBY SNY TEVA
Tags Briefs Movers SNY
From Benzinga
Sarepta Therapeutics' Duchenne Gene Therapy Shows Sustained Benefits And Disease Stabilization At Two Years
Tickers NEWS RHHBY SRPT
Tags Market News News Health Care
From Benzinga
Legal Marijuana Linked To Drop In Anxiety Medications: What It Means For Pharma Giants
Tickers NEWS PFE RHHBY
Tags Market News Health Care RHHBY
From Benzinga
Outlook Therapeutics Vision Loss Drug At Par With Novartis Drug
Tickers NEWS NVS OTLK RHHBY
Tags NVS Market News Health Care
From Benzinga
Sangamo Therapeutics Stock Plunges As Pfizer Terminates Hemophilia Gene Therapy Pact
Tickers ALPMF ALPMY NEWS PFE
Tags Stories That Matter Large Cap Trading Ideas
From Benzinga
Roche CEO Reassures No Job Cuts Despite Challenges: Report
Tickers NEWS RHHBF RHHBY
Tags RHHBY Equities News
From Benzinga
Roche-Prothena Partnered Mid-Stage Parkinson's Trial Misses Primary Endpoint, But Cling On Signs Of Clinical Benefits
Tickers NEWS PRTA RHHBY
Tags Market News Health Care RHHBY
From Benzinga
Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases
Tickers MRK NEWS RHHBY SNY
Tags Movers why it's moving Briefs
From Benzinga
United Kingdom's National Health Service Drug Spending Priorities Questioned in New Analysis
Tickers AZN EWU EWUS FKU
Tags General Top Stories FLGB
From Benzinga
Why Is Eye Disease-Focused Outlook Therapeutics Stock Trading Lower On Wednesday?
Tickers NEWS OTLK RHHBY
Tags Health Care RHHBY News
From Benzinga
Roche's Proposed Acquisition Of Poseida Therapeutics Poised To Establish New Core Capability In Cell Therapy For Cancer And Autoimmune Diseases: Details
Tickers NEWS PSTX RHHBY
Tags General why it's moving Movers
From Benzinga
Bristol-Myers Squibb Leads Biopharma Recovery With Almost 25% Growth In Market Cap, But Novo Nordisk And Lilly Suffer Market Setbacks
Tickers ABBV ALNY BMY GILD
Tags General SNY Movers
From Benzinga
Why Alphabet Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
Tickers AMBO AMD DBGI DJT
Tags NRDS STBX DBGI
From Benzinga
Roche's Q3 Sales Surge Led By Ocrevus, Vabysmo, Urges Regulators To Block Novo Holdings' $16.5B Catalent Acquisition
Tickers AMGN AZN CTLT GPCR
Tags AMGN General Top Stories
From Benzinga
Jazz Pharmaceuticals' Zepzelca/Tecentriq Combo Regimen Can Potentially Delay Disease Progression, Extend Survival In Aggressive Form Of Lung Cancer
Tickers JAZZ NEWS RHHBY
Tags Market News RHHBY Health Care
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.